There have been large numbers of studies on anti-HEV IgG seroprevalence in Europe,
however, the results of these studies have produced high variability of seroprevalence rates …

Hepatitis E is hyperendemic in many developing countries in Asia and Africa, and is caused
by hepatitis E virus (HEV) genotypes 1 and 2, which are spread via the faecal–oral route by …

The hepatitis E virus (HEV) sheds into feces as nonenveloped virions but circulates in the
blood in a membrane-associated, quasi-enveloped form (eHEV). Since the eHEV virions …

Hepatitis E virus (HEV) is a positive-strand RNA virus transmitted by the fecal-oral route. The
7.2 kb genome encodes three open reading frames (ORF) which are translated into (i) the …

Although most hepatitis E virus (HEV) infections are asymptomatic, some can be severe,
causing fulminant hepatitis and extra-hepatic manifestations, including neurological and …

Hepatitis E virus can cause acute, fulminant and chronic hepatitis and has been associated
with a range of extrahepatic manifestations. Guillain–Barré syndrome, neuralgic amyotrophy …

Hepatitis E virus (HEV) is the main cause of acute viral hepatitis worldwide. Its presence in
developing countries has been documented for decades. Developed countries were …

Hepatitis E virus (HEV) can lead to chronic infection in solid-organ transplant patients.
Ribavirin is efficient for treatment of chronically infected patients. Recently, the1634R …

Hepatitis E virus (HEV) infection is a major cause of acute hepatitis and affects more than 20
million individuals, with three million symptomatic cases and 56,000 recognized HEV …

The relevance of acute hepatitis E virus (HEV) infections has been underestimated for a long
time. In the past, HEV infection had been interpreted falsely as a disease limited to the …